Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

By The Northwire Desk — AI Analysis Dec 12, 2025 · 16:48 BLCO · 23.32 BAUSCH + LOMB CORPORATION
BLCO · Price

Executive Summary

  • Bausch + Lomb announced a $2,802,125,000 tranche of new “Replacement Term Loans” to refinance its existing term B loans due 2031 and 2028.
  • The new loans carry reduced margins – 0.50% lower for the 2031 loan and 0.25% lower for the 2028 loan – and will mature on January 15, 2031 (extending the 2028 loan).
  • The transactions are expected to close in Q1 2026, subject to customary closing conditions.

Key Details

  • Tranche Size: $2,802,125,000 of new term B loans (“Replacement Term Loans”).
  • Purpose: Full refinancing of all outstanding term B loans due 2031 (Third Amendment Term Loans) and due 2028 (First Incremental Term Loans).
  • Interest Margins:
  • 3.75% p.a. for Replacement Term Loans priced to SOFR (0.50% reduction vs. Third Amendment Term Loans).
  • 2.75% p.a. for Replacement Term Loans priced to an alternate base rate (0.25% reduction vs. First Incremental Term Loans).
  • Maturity: January 15, 2031 – same as the existing Third Amendment Term Loans; extends the First Incremental Term Loans from September 29, 2028 to 2031.
  • Closing Timeline: Anticipated in the first quarter of 2026, subject to completion risk.
  • Use of Proceeds: Entirely for refinancing the specified term loans; no additional corporate purposes disclosed.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from BAUSCH + LOMB CORPORATION

Jul 01, 2026 · 07:00

Dry Eye Survey Reinforces Premium Pricing Power, But Lacks Catalyst to Break Recent Consolidation

Other Jun 01, 2026 · 06:59

Bausch + Lomb Expands Dry Eye Portfolio with Preservative-Free Blink Launch; Execution on $7B Pipeline Continues Amid Margin Expansion

Financings May 19, 2026 · 07:00

Bausch + Lomb Executes H1 2026 Launch Plan Amidst Margin Expansion Push

Other May 07, 2026 · 07:00

Bausch + Lomb Expands Surgical Portfolio with European Bi-Blade+ Launch Amidst Guidance Raise

Other May 06, 2026 · 07:15

Bausch + Lomb Pipeline Webinar Confirms Long-Term Growth Narrative, But Near-Term Surgical Headwinds Persist Despite Q1 Guidance Raise

Other Apr 30, 2026 · 07:00

Bausch + Lomb Pipeline Validation Follows Q1 Guidance Raise Amidst Margin Expansion

Other